All-cause mortality risk with direct oral anticoagulants and warfarin in the primary treatment of venous thromboembolism

Oral anticoagulants used for the primary treatment of venous thromboembolism (VTE) include warfarin and the more recently introduced direct oral anticoagulants (DOACs), including rivaroxaban, apixaban, dabigatran, and edoxaban. Information on the comparative safety of these medications in routine cl...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Thromb Haemost
Hauptverfasser: Roetker, Nicholas S., Lutsey, Pamela L., Zakai, Neil A., Alonso, Alvaro, Adam, Terrence J., MacLehose, Richard F.
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2018
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6172009/
https://ncbi.nlm.nih.gov/pubmed/30103250
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1055/s-0038-1668521
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge